Employee healthcare navigation company Transcarent plans to acquire health benefits platform Accolade in a deal valued at ...

The acquisition of Accolade will combine its generative AI-powered WayFinding and care services, including Cancer Care, ...

A health care company with operations in Montgomery County is being acquired by California telehealth startup Transcarent in a $621 million cash deal.

A notable marriage is occurring in the world of digital health: Transcarent has claimed Accolade for $621 million. But by no means is this a marriage of equals given how the latter is being taken ...

Transcarent and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total ...

Accolade shareholders will receive $7.03 per share, a 110% premium over the stock’s Tuesday closing price of $3.35. The deal is expected to close in the second quarter of the year. Tullman told ...

When closed, the deal will take Accolade private and create a single firm with more than 1,400 employer and payer clients.

Transcarent agreed to acquire healthcare company Accolade for $7.03 a share in cash, bringing the equity value of the deal to around $621 million.

Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent’s Generative AI WayFinding and care ...

The Rams 2024 first-round pick was selected by Pro Football Network as their defensive rookie of the year after a dominating ...

Los Angeles Lakers star LeBron James will go down as one of the greatest players of all time, but he doesn't consider his ...

Transcarent, the One Place for Health and Care, and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in ...